![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 46, 42945-42956, November 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2-Cytoplasmic
Domain of LFA-1 Requires Intracellular Elements of the T Cell Receptor
Complex*
,
,
,
¶
From the
Laboratorium für Molekulare Biologie,
Genzentrum der Universität München, Feodor-Lynen-Str.
25 and the § Institut für Molekulare Immunologie,
GSF-Forschungszentrum für Umwelt und Gesundheit,
Marchioninistr. 25, D-81377 München, Germany
Received for publication, April 11, 2001, and in revised form, August 23, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The Activation of a T cell by cognate antigen is a complex series of
events of which specificity and efficiency are critical for the
development and maintenance of adaptive vertebrate immunity. The final
outcome of T cell activation, i.e. triggering of effector functions or induction of cytokine gene expression, is dependent on the
precise orchestration of plasma membrane proximal events, both at the
level of the involved receptors and the subsequent cytoplasmic signal
transduction cascades.
The specificity of T cell activation relies on the interaction of an
idiotypic TCR1 with antigenic
ligand on an antigen-presenting cell (APC). The activated TCR in turn
couples to an intracellular signal transduction apparatus, which is
predominantly based on specific tyrosine phosphorylation events (1, 2).
After phosphorylation of so-called immunoreceptor tyrosine-based
activation motifs (ITAMs), present in the intracellular elements of the
TCR-associated Signal transduction from the TCR, however, is not sufficient to fully
activate T cells. It has become evident that so-called accessory or
co-stimulatory receptors, e.g. CD28, expressed at the
surface of the T cell, are important determinants of this process.
Co-stimulatory interactions between other T cell surface proteins and
their self-ligands on APC have been hypothesized to deliver a
qualitatively different "signal 2" (as to distinguish it from
"signal 1" triggered by the TCR) (8, 9) and to influence cell-cell
tethering (10).
LFA-1 ( All these observations are consistent with the view that LFA-1 may not
deliver a second signal but rather could aid in amplifying the
TCR-dependent signal 1. However, its mode of action in this function is obscure. Here we use a chimeric receptor approach to
investigate the formal requirements of LFA-1 cytoplasmic domain elements in T cell signal transduction.
Cell Lines and Antibodies--
TAg-Jurkat cells and Jurkat
J.RT3-T3.5 T cells deficient in surface expression of the TCR were
maintained in RPMI 1640 supplemented with 10% fetal calf serum and 10 µg/ml gentamicin sulfate. The following antibodies were used in this
study: antigen affinity-purified goat anti-human IgG, Fc- DNA Constructs and Mutagenesis--
The cytoplasmic portions of
the transmembrane chimeras were amplified using PCR techniques and
cloned into a sIg expression plasmid p5C7 using the MluI and
NotI restriction sites (23). For construction of recombinant
vaccinia viruses, the coding segments were subcloned into the pTKG
vector (4). The intracellular domains of the respective transmembrane
fusion proteins comprised the following amino acid sequences: residues
725-769 (ALI ... AES*) of CD18, residues 1114-1170 (VGF ...
GKD*) of CD11a, residues 753-798 (LLM ... EGK*) of CD29 and
residues 183-220 (RSR ... YRS*) of CD28. The sIg-TCR-
Deletion mutants of the CD18 cytoplasmic tail comprised sIg-CD18-762*
residues 753-762 (ALI ... TVM*) or sIg-CD18-747* residues 753-747 (ALI ... SQW*). Point mutants of diverse chimeras were
generated using polymerase chain reaction-based strategies and resulted in substitution of phenylalanine 766 of CD18 for either alanine or
tyrosine or of tyrosine 795 of CD29 for phenylalanine.
Transfection of Jurkat T cells--
TAg-Jurkat and J.RT3-T3.5 T
cells were transfected with constructs coding for the chimeric proteins
by infection with recombinant vaccinia virus as described before (24).
Alternatively, Jurkat J.RT3-T3.5 T cells were transiently transfected
using the EasyjecT Plus electroporation system (Eurogentec, Seraing,
Belgium) as described previously (23).
Western Blot Analysis--
To verify protein levels of the
respective sIg chimeras, transfected TAg-Jurkat cells were lysed by
adding SDS to a final concentration of 1%. After adding 3× loading
buffer, samples were boiled for 5 min, separated by SDS-polyacrylamide
gel electrophoresis and transferred onto nitrocellulose membranes.
Immunodetection was performed using horseradish peroxidase-conjugated
secondary antibodies and chemiluminescence detection (PerkinElmer Life
Sciences). Alternatively, analysis of protein tyrosine phosphorylation
was performed by incubating transfected J.RT3-T3.5 T cells with
anti-human IgG antibody at 2 µg of antibody/6 × 106
cells for 5 min in Hanks' buffered saline solution at 37 °C before lysis with radioimmune precipitation buffer containing 1 mM
Na3VO4. Tyrosine-phosphorylated proteins were
visualized by Western blot analysis using 4G10 monoclonal antibody.
Intracellular Calcium Measurement--
Calcium mobilization
analysis was performed as described before (23). Briefly, TAg-Jurkat
and J.RT3-T3.5 T cells were transfected with chimeric transmembrane
constructs by infection with recombinant vaccinia virus. After 5 h
cells were washed, resuspended in Hanks' buffered saline solution, and
loaded with the fluorescent calcium probe Fluo-3 (Molecular Probes,
Inc., Eugene, OR) at 25 °C for 30 min. Fluorescence was measured by
flow cytometry for 30 s before anti-human IgG antibody was added
for stimulation of cells. The calcium influx was analyzed for a further
370 s, and mean values were calculated using the kinetic analysis
software Multitime 3.0 (Phoenix Flow Systems, San Diego, CA).
Src-kinase inhibitor PP2 (Calbiochem) was added at 10 µM
to Hanks' buffered saline solution where indicated. Calcium-free media
consisted of 10 mM Hepes, pH 7.5, 150 mM NaCl,
2 mM MgCl2, and 2 µM EGTA, respectively.
Cell-mediated Lympholysis--
CTL clone 234 was infected with
recombinant vaccinia viruses and incubated for 4 h. Cells were
harvested and subsequently incubated with target cells (BW-LCL,
HLA-A24+ or DS-LCL, HLA-A24 Interleukin-2 Promoter Reporter Assays--
Procedures for
transient transfection of TAg-Jurkat cells and measurement of
luciferase activity were described before (23). Briefly, 10 µg of
pIL2-GL2 reporter plasmid and 25 µg of respective sIg constructs were
cotransfected by electroporation. After 20 h, respective samples
were stimulated for 8 h as indicated with calcium ionophore A23187
(0.5 µg/ml) or phorbol 12-myristate 13-acetate (50 ng/ml) or by the
addition of cross-linking anti-human Ig antibody (5 µg/ml) or were
left untreated. This was followed by the addition of reporter lysis
buffer (Promega) and scintillation counting.
Integrin adhesion receptors do not bind constitutively to their
ligands. A large body of data indicates that the propensity of integrin
molecules to interact with cell surface receptors or extracellular
matrix ligands is regulated by intracellular signaling events that in
turn are triggered by "activating" receptor/ligand interactions
(integrin avidity regulation, "inside-out" signal transduction)
(11, 12, 26-29). One example is the aforementioned TCR, the activation
of which triggers enhanced binding of LFA-1 to its ligand ICAM-1 on an
APC (30). However, this property of the molecule complicates the study
of LFA-1-dependent signaling functions because the
integrin-mediated signal will be perturbed by the activation stimulus
required for the engagement of LFA-1 with its ligand. We hypothesized
that clustering of chimeric single-chain receptors bearing isolated
integrin cytoplasmic domains may be sufficient to induce signaling
events that would, under physiological conditions, emanate from these
elements in the context of the much more complex T cell activation
scenario. First, fusion proteins have been employed very successfully
in delineating signal transduction events triggered by the complex T
cell or B cell antigen receptors (4, 5, 31, 32). Second, strong
evidence supports the notion that integrin-dependent signal
transduction normally follows receptor aggregation or clustering. This
not only holds true for T cells, as evidenced by the observed
distribution of LFA-1 in supramolecular activation clusters (20), but
also is valid for non-hematopoietic cells adhering to extracellular
matrix components in which integrins signal through the formation of
higher order protein complexes (33, 34).
The structure of the single chain receptors used in this study is shown
in Fig. 1a, and the principal
design of these fusion proteins was described earlier (4, 5, 23). The
cytoplasmic domains of CD18 (
2 integrin LFA-1 is an
important cell-cell adhesion receptor of the immune system. Evidence
suggests that the molecule also participates in signaling and
co-stimulatory function. We show here that clustering of the
intracellular domain of the
2 chain but not of the
L- or
1-cytoplasmic domains,
respectively, triggers intracellular Ca2+ mobilization in
Jurkat cells. A
2-specific NPXF motif,
located in the C-terminal portion of the
2 tail, is
required for Ca2+ signaling, and we show that this motif is
important for the induction of allo-specific target cell lysis by
cytotoxic T cells in vitro. Significantly, the
Ca2+-signaling capacity of the
2 integrin is
abrogated in T cells that do not express the T cell receptor but may be
reconstituted by co-expression of the T cell receptor-
chain. Our
data suggest a specific function of the cytoplasmic domain of the
2 integrin chain in T cell signaling.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
chains or the CD3 complex (3, 4), a cross-talk of
non-receptor tyrosine kinases of the Src and Syk/ZAP-70 families
is initiated (5, 6) that relays signals between the TCR and distal
functions (i.e. cytokine promoter activation) (1, 7).
Specific hematopoietic adaptor proteins play important roles in
this information flow.
L
2, CD11a/CD18) belongs to a
family of heterodimeric cell surface proteins termed
2
integrins, which have primarily been shown to play important roles in T
cell adhesion to both endothelial cells and APC (11, 12). Recently,
LFA-1 has also been implicated in signal transduction (13-19). In one
study it was shown that the interaction of LFA-1 with its APC ligand
ICAM-1 was required for potentiation of Ca2+-signaling by
the TCR but was dispensable for T cell adhesion and spreading to major
histocompatibility complex-antigen complexes embedded in lipid
membranes (15). It was, therefore, suggested that the signaling
function of LFA-1 might even be more important for T cell activation
than its adhesive properties. On the other hand, Zuckerman
et al. (16) demonstrated that although LFA-1 cooperated
initially with the TCR to induce proliferation of naive T cells, this
signal led to apoptotic cell death after prolonged incubation periods.
Finally, recent studies indicate that after stimulation with specific
antigen, both the TCR and LFA-1 undergo specific reorientation and
reorganization processes at the plasma membrane, forming so-called
supramolecular activation clusters (20). A different study documented
similar structures, which were referred to as the immunological synapse
(21, 22). Supramolecular activation clusters also include other
co-stimulatory receptors as well as intracellular signaling molecules,
such as protein kinase C
(20).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
fragment-specific polyclonal antibody (Jackson ImmunoResearch, West
Grove, PA), monoclonal anti-CD4 antibody MT-151 (kindly provided by
Peter Rieber, University of Dresden), anti-phosphotyrosine antibody
4G10 (Upstate Biotechnology, Inc., Lake Placid, NY), and anti-LFA-1
antibody MEM-95 (kindly provided by Vaclav Horejsi, University of
Prague, Czech Republic). All secondary anti-IgG reagents were purchased
from Jackson ImmunoResearch.
construct (23) and the CD4-TCR-
construct (4, 24) were described before.
). Cell-mediated
lysis was quantified with the help of a standard 4-h chromium-51
release assay as described (25). Spontaneous release was determined by
incubating target cells alone in complete medium. Total release was
determined by directly counting an aliquot of labeled cells. The
percent cytotoxicity was calculated according to the formula % lysis = (experimental cpm
spontaneous cpm/total cpm
spontaneous cpm) × 100. Duplicate measurements of three to six
step titrations of effector cells were used for all experiments. To
evaluate the influence of LFA-1 on cytotoxicity, CD18 specific monoclonal antibody was incubated with clone 234 at room temperature for 30 min before the addition of target cells. The anti-CD18 monoclonal antibody MEM-95 (ascites) was used at a dilution of 1:100.
After preincubation with the antibody, the standard 4-h chromium
release assay was performed.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2 chain), CD11a
(
L chain), or the
-cytoplasmic domain of the related
1 integrin CD29 were genetically fused to the
transmembrane domain of the CD7 antigen and extended extracellularly by
the CH2 and CH3 domains of human immunoglobulin G1.
Secondary reagents directed against human IgG Fc fragments are used to
efficiently cluster the constant immunoglobulin domains. Furthermore,
the endoplasmic reticulum import signal sequence of CD5 (35) was used to mediate transport of the tripartite fusion proteins to the cell
surface of TAg-Jurkat cells (Figs. 1, b and
c).

View larger version (23K):
[in a new window]
Fig. 1.
Construction and characterization of
transmembrane sIg chimeras. a, schematic diagram of the
sIg fusion proteins. Two extracellular immunoglobulin domains were
genetically fused to the cytoplasmic portion (CPD) of either
the TCR-
chain, CD18, CD29, or CD11a or lacked any intracellular
tail (sIg-control). Expression of these sIg chimeras was achieved by
infecting TAg-Jurkat T with recombinant vaccinia viruses. Expression
levels were verified using anti-human IgG reagents either by
SDS-polyacrylamide gel electrophoresis of cell lysates followed by
Western blot analysis (b) or by measurement of cell surface
expression using flow cytometry (c). TMD,
transmembrane domain.
We first investigated whether the chimeras induced signaling events in
leukemic TAg-Jurkat T cells (36). We chose intracellular calcium
mobilization, a generally accepted and important parameter of receptor
proximal signaling events in T cells. Moreover, LFA-1 has been
implicated in this function (13, 15). To this end, the fusion proteins
were expressed in TAg-Jurkat cells by recombinant vaccinia viruses as
described earlier (5). Intracellular calcium mobilization was monitored
by flow cytometry using the fluorescent calcium chelator Fluo-3 (37).
Fig. 2 shows that base-line calcium levels are similar for all chimeric constructs used. However, after
clustering with antibody, specific induction of calcium mobilization
was observed.
|
A strong and persistent Ca2+-mobilization was induced by a
control fusion protein bearing the full-length cytoplasmic domain of
the TCR-associated
chain (Fig. 2a), as described
previously (4, 31). Significantly, however, an increase in cytoplasmic calcium concentration was also detected when the sIg-CD18 chimera was
clustered but not when control protein sIg bearing no intracellular domain or sIg-CD29 was employed. The CD18-dependent
Ca2+-flux appeared different from the sIg-TCR-
-induced
signal both in onset and amplitude. We conclude from these data that
the clustered cytoplasmic domain of CD18 is sufficient to induce
calcium signaling in TAg-Jurkat cells. It was subsequently analyzed
whether the intracellular portion of the
L chain (CD11a)
bore a similar capacity. Fig. 2b shows that this is not the
case. Furthermore, co-clustering of CD18 and CD11a did not enhance the
calcium signal induced by sIg-CD18 alone (not shown), which led us to
conclude that the aggregation-dependent signaling elements
of LFA-1 that lead to cytoplasmic calcium mobilization are located
exclusively within the CD18 cytoplasmic domain.
We attempted a preliminary characterization of intracellular signaling
events induced by sIg-CD18 clustering and of the routes of cytoplasmic
calcium mobilization. To this end, the Src kinase inhibitor PP2 was
employed in calcium mobilization assays. As shown in Figs.
3, a and b, the
addition of 10 µM PP2 to the medium abrogated both
sIg-
and sIg-CD18 mediated signals completely, suggesting that
CD18-mediated calcium signaling depends on Src kinase activity.
|
Is the CD18-dependent calcium signal dependent on
intracellular calcium stores ? To answer this question, calcium was
omitted from the medium, and the Ca2+-selective chelator
EGTA was added before flux measurement. Fig. 3c shows that
sIg-
induces a transient calcium flux in the absence of
extracellular calcium ions, consistent with the known
TCR-dependent calcium mobilization from intracellular
stores. However, sIg-CD18 was almost completely incapable of inducing
calcium transients in the presence of EGTA. This result hints at
differential requirements for the two receptors at a point further
downstream in the signaling cascade.
Reporter assays were then employed to study T cell signaling events that are located far downstream and which are known to be dependent on intracellular calcium mobilization. SIg-CD18 or a control construct were co-transfected with a luciferase reporter construct driven by the intact promoter/enhancer region of the human interleukin-2 promoter (23). Fig. 3d shows that cross-linking of sIg-CD18 resulted in a 5-fold, specific induction of the interleukin-2 promoter under these conditions. Moreover, co-transfection of a dominant-negative, kinase-deficient Lck construct, but not of intact Lck, abrogated CD18-dependent interleukin-2 promoter stimulation completely. These data are fully consistent with the loss of CD18-dependent calcium induction in the presence of Src kinase inhibitor PP2, and confirm a dependence of CD18 signal transduction on an Src kinase, which is likely Lck (Fig. 3a).
We were interested in determining whether the expression of the TCR was
important for sIg-CD18-mediated signal transduction. For these analyses
Jurkat J.RT3-T3.5 cells that do not express a TCR on the cell surface
were employed (38). Expression of all constructs was highly comparable
in TCR+ TAg-Jurkat cells and in J.RT3-T3.5 cells (Fig. 5
and data not shown). Fig. 4 shows that
Ca2+ mobilization was induced in J.RT3-T3.5 cells by the
sIg-TCR-
chimera as predicted, since this construct is thought to
function as a surrogate TCR. The sIg-CD18 fusion protein, however, did not induce cytoplasmic Ca2+-influx in the absence of the
TCR. We were interested in analyzing whether this deficiency was
because of a global inability of co-stimulatory molecules to function
properly in the absence of the TCR or the signaling components it might
assemble. Therefore, a different fusion protein was employed that bore
the intact cytoplasmic domain of CD28, which has previously been
implicated in Ca2+ signaling. The corresponding data are
also shown in Fig. 4. It was observed that the CD28 fusion protein was
functional both in TAg-Jurkat cells and in J.RT3-T3.5 cells (Fig. 4 and
data not shown), although the amplitude of the Ca2+ flux in
J.RT3-T3.5 was on the average lower than in TAg-Jurkat cells (data not
shown). These data indicate that the CD28 fusion protein was capable of
delivering signals that were independent of the TCR to a significant
extent, whereas the signal induced by the CD18 chimera strictly
required TCR cell surface expression.
|
These findings prompted us to analyze which components of the TCR were
needed for CD18-dependent functions. Therefore, we adapted
our system to the simultaneous use of two fusion proteins that could be
independently clustered on the surface of the same cell. Fig.
5a shows the design of the
additional constructs. In this system, the cytoplasmic and
transmembrane portions of TCR-
were fused to the extracellular
domain of CD4, or alternatively, full-length CD4 was used as a
control.
|
Experiments were performed to determine whether the sIg or CD4
derivatives could be co-expressed and independently manipulated on the
surface of J.RT3-T3.5 cells. Fig. 5 shows that this is the case.
Co-expression was monitored by flow cytometric analysis using anti-Ig
antibodies and anti-CD4 antibody MT151 (Figs. 5, b and
d). Clustering of the CD4-TCR-
fusion protein resulted in
Ca2+ mobilization as expected (not shown). Moreover,
sIg-CD18-dependent signal transduction was not
reconstituted by co-expression of CD4 (Fig. 5c), and
aggregation of an sIg control protein did not result in
Ca2+ mobilization even when CD4-TCR-
was present on the
same cell surface (Fig. 5e). These data indicate that the
antibodies employed targeted the surface chimeras in a highly specific
fashion. Therefore, inadvertent antibody-mediated co-aggregation of
these molecules could be excluded. It was consequently determined
whether the expression of CD4-TCR-
was sufficient to rescue the
sIg-CD18-mediated Ca2+ flux. Fig. 5e shows that
this was indeed the case. We conclude that the TCR-associated
chain
suffices to promote CD18-dependent Ca2+ signaling.
Tyrosine phosphorylation of cytoplasmic components is an important
event in receptor-mediated T cell activation. Therefore, experiments
were performed to determine whether sIg-CD18 was capable of inducing
cytoplasmic tyrosine phosphorylation events in J.RT3-T3.5 cells. The
results of this experiment are shown in Fig. 5f. The left lane shows that in the absence of a co-expressed
CD4-TCR-
fusion protein only the other TCR-
chimera
(sIg-TCR-
), but not sIg-CD18, was capable of inducing tyrosine
phosphorylation of a number of protein bands. This was different,
however, when sIg-CD18 and CD4-TCR-
were co-expressed on the surface
of J.RT3-T3.5 cells. After clustering of the sIg-CD18 construct, we
observed a tyrosine phosphorylation pattern that was qualitatively
similar to that induced by sIg-TCR-
. We conclude that signal
transduction by the CD18 cytoplasmic domain progresses intracellularly
through tyrosine phosphorylation events and that the TCR-
chain
plays an important role in this process. To further corroborate this evidence, Fig. 5g shows protein tyrosine phosphorylation in
TAg-Jurkat cells with or without specific surface chimera aggregation.
Both antibody-aggregated sIg-CD18 and sIg-
strongly induce
phosphorylation of a 38-kDa band, which corresponds well to the T cell
receptor-dependent phosphorylation target LAT, which is the
predominant T cell activation-induced phosphoprotein of the respective
molecular weight range. The 38-kDa phosphoprotein was not detectable in
total lysates when sIg-CD29 or sIg alone were employed (Fig.
5g). All these observations are compatible with the notion
that CD18 couples to a signaling apparatus that shares important
components with the TCR-associated machinery, at least with respect to
Ca2+ signaling.
In the following we dissected the requirements of CD18 cytoplasmic
domain elements for Ca2+ signal transduction. To this end,
C-terminal deletion mutants were generated (Fig.
6, a and b). Fig.
6c shows that deletion of the C-terminal seven amino acids
(sIg-CD18-762*) abrogated the signal completely. Further deletion
(sIg-CD18-747*) had no effect, confirming that the C-terminal residues
were required for the observed function. This C-terminal element bears
an NPXF motif, and similar motifs have been implicated in
receptor internalization pathways. Interestingly, the cytoplasmic
domains of CD18 and CD29 (
1 integrin) display
significant differences in this region (Fig. 8a). We,
therefore, produced a series of point mutants to test whether these
structural differences were responsible for the observed functional
specificity. For this purpose, phenylalanine 766 of CD18 was mutated
into either alanine or tyrosine by standard molecular biology
techniques, and the resulting mutants (Fig. 7, a and b) were
tested for their respective abilities to induce cytoplasmic
Ca2+ mobilization after clustering. Fig. 7c
shows that Ca2+ signaling was completely abrogated when the
F766A mutant was employed. A strong reduction of measurable signal was
also observed for the F766Y mutant, leading to an unstable flux.
|
|
Consequently it was analyzed to determine whether the CD29 fusion
protein could be induced to couple to the Ca2+ pathway by
exchanging tyrosine 795 (of the corresponding
1
NPXY motif) for phenylalanine (Fig.
8, a and b).
Indeed, it was observed that the sIg-CD29 chimeras became partially
functional by this manipulation (Fig. 8c). On the other
hand, replacement of the C-terminal eight residues of CD29 with the
ones of CD18 (CD29-cyt/ex) resulted in an
inactive construct (Fig. 8c). Taken together, these data
indicate that phenylalanine 766 of the CD18 cytoplasmic domain is an
important determinant of LFA-1-dependent Ca2+
signaling. However, our data also indicate that the C-terminal amino
acid environments of CD18 and CD29 influence the capacity of the
homologous Phe or Tyr residues, respectively, to actively engage with
the downstream machinery.
|
We finally attempted to demonstrate that our findings bear significance
for more complex T cell activation events. Cytotoxic T cell function
was investigated because the requirement for LFA-1 has been very well
documented for both cytotoxic T lymphocytes (CTL) and for natural
killer cells (39). Allo-recognition-dependent target cell
killing of HLA-A24-restricted cytotoxic T cell clone 234 was employed
as an experimental system (40). It was first determined whether
234-mediated killing of BW-LCL, i.e. the target cells that
express the correct haplotype HLA-A24 alloantigen, was
LFA-1-dependent. To this end, anti-LFA-1 antibody MEM-95
was utilized to abrogate LFA-1 binding to ICAM-1 (41). As expected, Fig. 9b shows that
234-dependent killing of BW-LCL was strongly dependent on
LFA-1/ICAM-1 interaction since MEM-95 specifically inhibited cell
lysis.
|
SIg fusion proteins were then expressed in 234 cells by recombinant
vaccinia viruses, and the infected cells were employed in killing
assays (Fig. 9c). The rationale underlying this experiment was as follows. It has well been documented that integrin function may
be inhibited by isolated overexpression of
-chain cytoplasmic domains or cytoplasmic domain fusion proteins similar to those employed
in our study (42-44). This observation was interpreted as a dominant
block that the
-cytoplasmic domains exert on the endogenous
integrins by titrating important functional, cellular components of the
membrane or the cytoplasm. Moreover, this approach has been developed
into a functional complementation system in which overexpression of a
cDNA library was utilized to overcome the dominant block exhibited
by the
-chain construct, thus leading to the identification of novel
components of the integrin "inside-out" signaling pathway (45).
We reasoned that if the sIg-CD18 fusion protein acted in an inhibitory
fashion on the cytotoxic potential of 234, this should suffice to
document the importance of the cytoplasmic domain of CD18 for the
allo-recognition-dependent activation of cytotoxic T cells.
Fig. 9 shows that this was indeed the case. SIg-CD18 but not an
sIg-control construct significantly inhibited 234-mediated lysis of
BW-LCL. Moreover, and importantly, this inhibition was released when
the sIg-CD18-F766Y mutant was employed (Fig. 9c). This
observation is consistent with the notion that residue Phe-766 of CD18
is involved in signaling events important for CTL activation. Furthermore, these findings are in full concordance with the Jurkat experiments on calcium signaling described above.
| |
DISCUSSION |
|---|
|
|
|---|
We describe here signal transduction events that are specifically
initiated by the cytoplasmic domain of the
2 integrin
CD18. Clustering of single-chain fusion proteins was employed to induce changes in intracellular calcium levels. By exploring this system it
was found that aggregation of the intact
2-cytoplasmic
domain was sufficient for triggering a calcium signal in TAg-Jurkat
cells. Significantly, neither the
L-cytoplasmic domain
nor the cytoplasmic tail of the
1 integrin CD29 bore
this capacity. These results suggest a previously unknown differential
ability of specific integrin cytoplasmic domains to stimulate signal
transduction events in T cells. The system was chosen because
2 integrins require intracellular activation to
facilitate ligand binding. This adhesion-dependent
signaling will normally be difficult to discern from the processes
initiated by the activation stimulus. Our system circumvents such an
activation requirement and, furthermore, operates independently of
adhesion and spreading, which in turn might trigger complex signaling
systems (e.g. through cytoskeletal reorganization). Although
changes in cell shape and morphology might contribute to cellular
activation in important ways, it is necessary to be able to
discriminate among these parameters to determine the minimal
requirements for signaling.
The functional elements of integrin cytoplasmic domains have been
analyzed in great detail in terms of their relative contribution to
cell adhesion and spreading, but their potential roles in signal transduction have not been explored. For the
2-cytoplasmic domain, these regions can be grouped into
membrane proximal and distal functional elements. The binding sites for
actin-cytoskeletal linker proteins, such as
-actinin or filamin (46,
47), are located in the N-terminal portion of the
2 tail
in addition to the response element for regulatory protein cytohesin-1,
as recently described (41). More distal elements include the 758-60
TTT motif, which was shown to be required for constitutive adhesion of
LFA-1 to ICAM-1 in COS cells (48) and for spreading of
2/
3 chimera in an ectopic expression
system (49). Our results show that the deletion of the C-terminal seven
amino acids abrogates the
2-dependent
calcium signal. Therefore, none of the above-mentioned elements appears
to be sufficient for calcium mobilization because they are all present
in the non-functional construct CD18-762*. However, the C terminus of
two so-called NPXF motifs is deleted in this mutant.
Moreover, mutation of the NPXF-phenylalanine into either a
non-conserved alanine or a conserved tyrosine residue abrogated or
strongly impeded the abilities of the resulting chimeras to induce a
calcium flux. These data strongly suggest that the calcium signaling
capacity of the
2-cytoplasmic domain is largely dependent on the C-terminal NPXF motif. Interestingly, the
1-cytoplasmic domain of integrin CD29 bears an
NPXY motif at the homologous position. This finding prompted
us to analyze whether the reversal of a single amino acid in
1 (Y759F) would rescue the calcium signaling capacity of
the
1 fusion protein. Fig. 7c shows that this is
partially the case. We conclude from these data that phenylalanine 766 of the distal NPXF motif is a specific determinant of
2-dependent intracellular calcium
mobilization. However, the functionality of this motif appears to be
somewhat dependent on the neighboring amino acids. This might be
because of specific conformations that the different
tails assume;
in fact, the contribution of integrin cytoplasmic tail conformation to
function has recently been suggested (50). In an earlier study, F766
was shown to be an important determinant of
LFA-1-dependent, constitutive adhesion of COS7 cells to
ICAM-1. However, mutation of this residue into alanine had a strong
inhibitory effect on adhesion whereas exchange of phenylalanine into
tyrosine had yielded no phenotypic changes (48). The involvement of
this region in signal transduction apparently is a different one.
Firstly, the F766Y mutant bears little capacity to flux calcium and,
secondly cytotoxic T cell function was strongly inhibited by the
sIg-CD18 fusion protein but not by the F766Y mutant, suggesting that
this mutant could not exert a dominant-negative block on the activation
of specific cytolysis. Taken together, our data suggest that the distal
NPXF has a different function in T cell signal transduction,
as compared with COS cell adhesion to ICAM-1 mediated by ectopic LFA-1
expression. It cannot fully be ruled out, however, that some of the
observed differences may be because of the cell types employed. The
relative contribution of the C-terminal NPXF motif to signal
transduction or T cell adhesion, respectively, would thus have to be
analyzed in the future.
NPX(F/Y) motifs have also been implicated in receptor
internalization. Specifically, the cytoplasmic tail requirements for endocytosis of LFA-1 have recently been analyzed. Based on this study,
the determinant for the internalization of the
2
integrin lies further N-terminal in the
2-cytoplasmic
domain and, thus, does not overlap with the C-terminal NPXF
motif (51).
Recent evidence suggests that platelet function in vivo is
dependent on
3-integrin signaling through NPXY and
NXXY motifs. Interestingly, in the case of the
IIb
3 receptor this loss-of-function correlates with abrogation of receptor tyrosine phosphorylation (52).
Thus, in different contexts both NPXF and
NPXY motifs may contribute to specific signaling events.
We observed that the ability of the CD18 fusion protein to promote
calcium mobilization is dependent on the expression of either an intact
TCR or the
chain fusion protein. These results suggest that LFA-1
acts on elements that are utilized or organized by TCR-
, or it acts
through the
chain itself. It may be possible that co-clustering of
the receptors is mediated through links between their cytoplasmic
portions. However, initial experiments (not shown) on TCR or
chain
co-aggregation after clustering of the integrin chimera do not support
this idea. Intriguingly, one study has shown that the
-associated
tyrosine kinase ZAP-70 functions in an LFA-1 to LFA-1 adhesion
regulation pathway important for cell invasiveness, but a direct link
between the molecules has not been established (53). In light of our
observations it is possible that the T cell receptor complex and LFA-1
coordinately relay information important for both cell activation and
migratory functions. Several groups have recently shown that
integrin-mediated matrix adhesion and growth factor receptors
coordinately regulate cell proliferation (54-56). The underlying
mechanisms are poorly understood, but it was suggested that
extracellular matrix enhances PDGF-dependent responses by
increasing the association of SHP-2 with platelet-derived growth factor
receptor
(57). In the light of our results, one is tempted to
hypothesize that
2 integrin signaling may also provide a
means of modulating ITAM (immunoreceptor tyrosine-based activation
motifs) dependent immunoreceptor function. It should further
be noted that signaling of other receptors in T cells (CD2, CD4) had
been shown to display similar requirements for the presence of TCR
functional elements (58, 59).
It is currently not known at which level the NPXF motif of
the
2-cytoplasmic domain and the TCR-associated
chain functionally interact. Recently, a transcription factor termed
JAB1 had been found to interact with the
2-cytoplasmic
domain; furthermore, this protein was translocated to the nucleus
clustering of LFA-1 (60). It is presently not known, however, whether
this interaction is important for T cell activation and, if so, whether
it affects calcium signaling. Moreover, the precise binding site for
JAB1 within the
2-cytoplasmic domain has not yet been determined.
Substantial evidence supports the notion that Src family kinases are
important downstream effectors of integrin signaling (61, 62).
Furthermore, the Lck kinase in T cells plays a critical role in T cells
with respect to ITAM phosphorylation, and its subsequent downstream
interaction with ZAP-70 is critical for phospholipase C
activation
and calcium signaling (63). However, convincing molecular links between
Src kinases and integrin cytoplasmic domains have not yet been
determined. Our results support the contention that functional
interaction occurs between the C-terminal NPXF motif of the
2 tail and Src kinases in T cells. Moreover, there is
evidence for functional interaction of LFA-1 with the cytotoxic T cell
surface receptor DNAM-1 (64). DNAM-1 has been shown to be
phosphorylated on tyrosine residues after aggregation of LFA-1, and
this process appears to involve the Fyn kinase. Interestingly, we found
that the sIg-CD18 chimera did not signal in the absence of
extracellular calcium (Fig. 3c), nor did it induce
phospholipase C
phosphorylation. On the other hand, induction of a
38-kDa phosphotyrosine was observed, consistent with the activation of
LAT, a major phosphorylation target of ZAP-70 in T cells (65). We were
unfortunately not capable of proving this point directly, since
immunoprecipitation of LAT from TAg-Jurkat cells failed under the
conditions used. These findings point to distinct similarities but also
to differences between
2 integrin and T cell
receptor-induced signaling pathways. Significantly, Takata et
al. (66) describe differential signaling routes to calcium
mobilization in DT40 B cells; these authors concluded that the Src
kinase Lyn might regulate Ca2+ mobilization through a
process independent of inositol 1,4,5-trisphosphate generation. It is
possible that CD18 couples to a similar pathway in T cells
Our data provide a specific and testable hypothesis on the role of
2 integrin-mediated signaling events in T cell
activation. This may now be verified in more complex systems, which
allow the analysis of heterodimeric molecules. In the course of this study we have attempted to reconstitute wild-type and mutant
2 chain expression in
2
allo-specific
leukocyte adhesion deficiency T cell clones (not shown). However, this
model system did not in principle allow visualization of calcium
signaling induced by the allotype and was therefore not useful for our
purposes. Therefore, reconstitution of wild-type and mutant
2 chains in
2 knock-out animals and
subsequent analysis of their T cell function in vivo appears
as a plausible direction for future work.
Taken together our findings suggest that
2 integrins
specifically contribute to Ca2+ signaling in T cells
through an NPXF motif of the
2-cytoplasmic domain. These data further support and extend an emerging general theme
of signal integration in cell growth regulation operating through
functional interactions of integrins with growth factor receptors.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Rudolf Grosschedl and Ernst Winnacker for continuing support. We further thank Rudolf Wank for providing CTL clone 234, Yvette van Kooyk for providing an leukocyte adhesion deficiency T cell clone, Vaclav Horejsi and Peter Rieber for the donation of antibodies, and members of the lab for discussion and advice.
| |
FOOTNOTES |
|---|
* This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 464, SFB 455, and SFB 190 and by the Wilhelm-Sander-Stiftung.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 49-89-2180-6878 (or 6886 or 6884); Fax: 49-89-2180-6999; E-mail: kolanus@lmb.uni-muenchen.de.
Published, JBC Papers in Press, September 14, 2001, DOI 10.1074/jbc.M103224200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: TCR, T cell receptor; LFA-1, lymphocyte function-associated antigen-1; APC, antigen-presenting cell; ICAM-1, intercellular adhesion molecule-1; CTL, cytotoxic T lymphocyte; LAT, linker in T cell activation.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Weiss, A., and Littman, D. R. (1994) Cell 76, 263-274[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Kane, L. P., Lin, J., and Weiss, A. (2000) Curr. Opin. Immunol. 12, 242-249[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Reth, M. (1989) Nature 338, 383-384[Medline] [Order article via Infotrieve] |
| 4. | Romeo, C., Amiot, M., and Seed, B. (1992) Cell 68, 889-897[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Kolanus, W., Romeo, C., and Seed, B. (1993) Cell 74, 171-183[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Chan, A. C., Dalton, M., Johnson, R., Kong, G. H., Wang, T., Thoma, R., and Kurosaki, T. (1995) EMBO J. 14, 2499-2508[Medline] [Order article via Infotrieve] |
| 7. | van Leeuwen, J. E., and Samelson, L. E. (1999) Curr. Opin. Immunol. 11, 242-248[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. (1996) Annu. Rev. Immunol. 14, 233-258[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Chambers, C. A., and Allison, J. P. (1999) Curr. Opin. Cell Biol. 11, 203-210[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Watts, T. H., and DeBenedette, M. A. (1999) Curr. Opin. Immunol. 11, 286-293[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Diamond, M. S., and Springer, T. A. (1994) Curr. Biol. 4, 506-517[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Lub, M., van Kooyk, Y., and Figdor, C. G. (1995) Immunol. Today 16, 479-483[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Kanner, S. B.,
Grosmaire, L. S.,
Ledbetter, J. A.,
and Damle, N. K.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7099-7103 |
| 14. |
Wulfing, C.,
and Davis, M. M.
(1998)
Science
282,
2266-2269 |
| 15. |
Wulfing, C.,
Sjaastad, M. D.,
and Davis, M. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6302-6307 |
| 16. |
Zuckerman, L. A.,
Pullen, L.,
and Miller, J.
(1998)
J. Immunol.
160,
3259-3268 |
| 17. | Bachmann, M. F., McKall-Faienza, K., Schmits, R., Bouchard, D., Beach, J., Speiser, D. E., Mak, T. W., and Ohashi, P. S. (1997) Immunity 7, 549-557[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Sedwick, C. E.,
Morgan, M. M.,
Jusino, L.,
Cannon, J. L.,
Miller, J.,
and Burkhardt, J. K.
(1999)
J. Immunol.
162,
1367-1375 |
| 19. |
Abraham, C.,
Griffith, J.,
and Miller, J.
(1999)
J. Immunol.
162,
4399-4405 |
| 20. | Monks, C. R., Freiberg, B. A., Kupfer, H., Sciaky, N., and Kupfer, A. (1998) Nature 395, 82-86[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Grakoui, A.,
Bromley, S. K.,
Sumen, C.,
Davis, M. M.,
Shaw, A. S.,
Allen, P. M.,
and Dustin, M. L.
(1999)
Science
285,
221-227 |
| 22. | Dustin, M. L., and Cooper, J. A. (2000) Nat. Immunol. 1, 23-29[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Zeitlmann, L.,
Knorr, T.,
Knoll, M.,
Romeo, C.,
Sirim, P.,
and Kolanus, W.
(1998)
J. Biol. Chem.
273,
15445-15452 |
| 24. | Romeo, C., Kolanus, W., Amiot, M., and Seed, B. (1992) Cold Spring Harbor Symp. Quant. Biol. 57, 117-125[Medline] [Order article via Infotrieve] |
| 25. | Schendel, D. J., Wank, R., and Dupont, B. (1979) Tissue Antigens 13, 112-120[Medline] [Order article via Infotrieve] |
| 26. | Hynes, R. O. (1992) Cell 69, 11-25[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Kolanus, W., and Seed, B. (1997) Curr. Opin. Cell Biol. 9, 725-731[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Hughes, P. E., and Pfaff, M. (1998) Trends Cell Biol. 8, 359-364[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Hemler, M. E. (1998) Curr. Opin. Cell Biol. 10, 578-585[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Dustin, M. L., and Springer, T. A. (1991) Annu. Rev. Immunol. 9, 27-66[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Irving, B. A., and Weiss, A. (1991) Cell 64, 891-901[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Reth, M., and Wienands, J. (1997) Annu. Rev. Immunol. 15, 453-479[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Giancotti, F. G.,
and Ruoslahti, E.
(1999)
Science
285,
1028-1032 |
| 34. | Aplin, A. E., Howe, A. K., and Juliano, R. L. (1999) Curr. Opin. Cell Biol. 11, 737-744[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Zettlmeissl, G., Gregersen, J. P., Duport, J. M., Mehdi, S., Reiner, G., and Seed, B. (1990) DNA Cell Biol. 9, 347-353[Medline] [Order article via Infotrieve] |
| 36. | Clipstone, N. A., and Crabtree, G. R. (1992) Nature 357, 695-697[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Kao, J. P.,
Harootunian, A. T.,
and Tsien, R. Y.
(1989)
J. Biol. Chem.
264,
8179-8184 |
| 38. |
Weiss, A.,
and Stobo, J. D.
(1984)
J. Exp. Med.
160,
1284-1299 |
| 39. | Springer, T. A., Rothlein, R., Anderson, D. C., Burakoff, S. J., and Krensky, A. M. (1985) Adv. Exp. Med. Biol. 184, 311-322[Medline] [Order article via Infotrieve] |
| 40. |
Besser, M.,
and Wank, R.
(1999)
J. Immunol.
162,
6303-6306 |
| 41. | Geiger, C., Nagel, W., Boehm, T., van Kooyk, Y., Figdor, C. G., Kremmer, E., Hogg, N., Zeitlmann, L., Dierks, H., Weber, K. S., and Kolanus, W. (2000) EMBO J. 19, 2525-2536[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Retta, S. F.,
Balzac, F.,
Ferraris, P.,
Belkin, A. M.,
Fassler, R.,
Humphries, M. J.,
De Leo, G.,
Silengo, L.,
and Tarone, G.
(1998)
Mol. Biol. Cell
9,
715-731 |
| 43. |
Lukashev, M. E.,
Sheppard, D.,
and Pytela, R.
(1994)
J. Biol. Chem.
269,
18311-18314 |
| 44. |
LaFlamme, S. E.,
Thomas, L. A.,
Yamada, S. S.,
and Yamada, K. M.
(1994)
J. Cell Biol.
126,
1287-1298 |
| 45. | Fenczik, C. A., Sethi, T., Ramos, J. W., Hughes, P. E., and Ginsberg, M. H. (1997) Nature 390, 81-85[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Sampath, R.,
Gallagher, P. J.,
and Pavalko, F. M.
(1998)
J. Biol. Chem.
273,
33588-33594 |
| 47. | Sharma, C. P., Ezzell, R. M., and Arnaout, M. A. (1995) J. Immunol. 154, 3461-3470[Abstract] |
| 48. | Hibbs, M. L., Jakes, S., Stacker, S. |